RDInvesting Provides Stock Research on CVR Energy and Phillips 66
Continue ReadingTag: equity-research
Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success
Five Star Equities Provides Stock Research on Array Biopharma and PDL BioPharma
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
RDInvesting Provides Stocks Research on Acura Pharmaceuticals and Sunesis Pharmaceuticals
Continue Reading
U.S. Oil Refiners Slump on Concerns of Lower Margins Due to Rising Renewable Fuel Credits
RDInvesting Provides Stock Research on HollyFrontier and Valero Energy
Continue Reading
Dividends From the Dow 30 Reach Highest Level Since Before the Financial Crisis
RDInvesting Provides Stock Research on Johnson & Johnson and Merck
Continue Reading
Long-Term Outlook for Uranium Demand Positive as Approximately 500 Nuclear Reactors Planned/Under Contruction
Five Star Equities Provides Stock Research on Ur-Energy and Uranerz Energy
Continue Reading
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry-s Growth in 2012
Five Star Equities Provides Stock Research on Affymax and DARA Biosciences
Continue Reading
Long-Term Demand for Uranium to Be Driven by Emerging Nation — Miners Could Receive Boost From End of Russia-s Disarmament Treaty
Five Star Equities Provides Stock Research on Cameco and Denison Mines
Continue Reading
FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
Five Star Equities Provides Stock Research on AEterna Zentaris and Amicus Therapeutics
Continue Reading
Smartphone Demand Continues to Drive Growth Within Technology Sector — Smartphones Expected to Outsell Feature Phones in 2013
RDInvesting Provides Stock Research on Millennial Media and Vringo
Continue Reading